We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

124 hedge funds and large institutions have $90.5M invested in Coherus Oncology in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,679% more call options, than puts

Call options by funds: $7.36M | Put options by funds: $154K

13% more capital invested

Capital invested by funds: $79.9M → $90.5M (+$10.6M)

3% less funds holding

Funds holding: 128 → 124 (-4)

9.85% less ownership

Funds ownership: 66.79% → 56.94% (-9.8%)

11% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 35

12% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 34

Holders
124
Holders Change
-4
Holders Change %
-3.13%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
30
Reduced
34
Closed
35
Calls
$7.36M
Puts
$154K
Net Calls
+$7.21M
Net Calls Change
+$7.2M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.93M
2
TCM
Tang Capital Management
California
+$1.46M
3
Morgan Stanley
Morgan Stanley
New York
+$1.44M
4
UBS Group
UBS Group
Switzerland
+$601K
5
Millennium Management
Millennium Management
New York
+$283K

Top Sellers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
-$5.77M
2
Citadel Advisors
Citadel Advisors
Florida
-$3.21M
3
Barclays
Barclays
United Kingdom
-$2.43M
4
Goldman Sachs
Goldman Sachs
New York
-$1.73M
5
BlackRock
BlackRock
New York
-$983K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northwestern Mutual Wealth Management
101
Northwestern Mutual Wealth Management
Wisconsin
$10.1K – – –
Nisa Investment Advisors
102
Nisa Investment Advisors
Missouri
$6.45K +$744 +663 +17%
TWD
103
True Wealth Design
Ohio
$5.93K +$1.94K +1,728 +67%
Osaic Holdings
104
Osaic Holdings
Arizona
$5.09K -$88 -78 -2%
AB
105
Amalgamated Bank
New York
$5K – – –
US Bancorp
106
US Bancorp
Minnesota
$4.14K – – –
SCM
107
Sterling Capital Management
North Carolina
$3.9K +$2.84K +2,535 +880%
MWA
108
Medallion Wealth Advisors
Connecticut
$2.86K +$2.32K +2,070 New
SC
109
Swan Capital
Florida
$1.79K – – –
EWA
110
EverSource Wealth Advisors
Alabama
$1.76K +$1.44K +1,279 New
SS
111
SBI Securities
Japan
$1.03K +$839 +748 New
Russell Investments Group
112
Russell Investments Group
United Kingdom
$1.02K +$833 +743 New
IA
113
IFP Advisors
Florida
$309 +$251 +224 New
CIAS
114
CBIZ Investment Advisory Services
Ohio
$215 +$175 +156 New
LFG
115
Larson Financial Group
Missouri
$203 – – –
RS
116
R Squared
Hong Kong
$193 +$157 +140 New
CIBC Private Wealth Group
117
CIBC Private Wealth Group
Georgia
$186 – – –
PNC Financial Services Group
118
PNC Financial Services Group
Pennsylvania
$135 – – –
FFA
119
Farther Finance Advisors
California
$65 +$53 +47 New
CPG
120
Cornerstone Planning Group
New Jersey
$57 – – –
CWP
121
Clark Wealth Partners
Illinois
$32 +$26 +23 New
AWM
122
AllSquare Wealth Management
New York
$22 – – –
HNB
123
Huntington National Bank
Ohio
$1 – – –
Citadel Advisors
124
Citadel Advisors
Florida
– -$3.21M -2,857,208 Closed
Lazard Asset Management
125
Lazard Asset Management
New York
– -$919K -883,729 Closed
3 4
5
6 7

CHRS Hedge Fund Activity: Q4 2024 in Review

124 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2024, worth a combined $90.5M — up 13% from $79.9M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CHRS and 31 opened new positions — a net loss of 4 holders — while 34 trimmed existing stakes and 30 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.93M. The largest seller was Rubric Capital Management (New York), cutting an estimated $5.77M.

  • 124 institutional investors held Coherus Oncology (CHRS) as of Q4 2024, down from 128 in Q3 2024.
  • Funds reported $90.5M of Coherus Oncology stock for Q4 2024, up 13% quarter-over-quarter.
  • 31 funds opened new Coherus Oncology positions in Q4 2024 and 35 closed out, a net change of -4 holders.
  • The largest Coherus Oncology buyer in Q4 2024 was Point72 Asset Management, an estimated $5.93M added.
  • The largest Coherus Oncology seller in Q4 2024 was Rubric Capital Management (New York), an estimated $5.77M sold.

Based on aggregated 13F filings for Q4 2024.